{
  "trial_id": "NCT03024463",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Internal mammary sentinel lymph node biopsy (IM-SLNB) provides a less invasive method of assessing the IMLN than surgical dissection.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The modified radiotracer injection technique could significantly improve the IM-SLN detection rate.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Axillary sentinel lymph node biopsy has a high success rate and accuracy.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The patient is able and willing to sign informed consent forms.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who have received neoadjuvant therapy (including neoadjuvant chemotherapy and / or endocrine therapy).",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Patients with a previous history of breast cancer.",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient is eligible for the trial based on inclusion criteria and exclusion criteria.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT03024463",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}